CGP-6809
CGP-6809 is an orally active DNA inhibitor. CGP-6809 exhibits antitumor activity against various transplantable tumors in mice and rats, including melanoma, prostate cancer, and rectal cancer. CGP-6809 can be used in research on various cancers, including melanoma, prostate cancer, and rectal cancer[1][2].
Product Specifications
CAS Number
70457-70-4
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=NN(C)C(NC[C@H]([C@]1([H])[C@@H]([C@H]([C@H](O1)OCC)O)OC)OC)=O
Molecular Formula
C12H23N3O7
Molecular Weight
321.33
References & Citations
[1]Schieweck K, et al. CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties. Cancer Chemother Pharmacol. 1989;23 (6) :341-7. |[2]Fiebig HH, et al. CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts. Cancer Chemother Pharmacol. 1989;23 (6) :337-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
216112 50 µg
ADAM15 (ADAM-15, A Disintegrin and Metalloproteinase Domain 15)
Sign In for Pricing
View Details 
MBS1082626-01 0.02 mg (E-Coli)
Recombinant Geobacter uraniireducens UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details MBS1082626-02 0.02 mg (Yeast)
Recombinant Geobacter uraniireducens UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details